Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Translations
    • Topics A-Z
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Translations
    • Topics A-Z
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Articles
  • Issues
  • Practice Current
  • Practice Buzz

User menu

  • Subscribe
  • My Alerts
  • Log in
  • Log out

Search

  • Advanced search
Neurology Clinical Practice
Home
A peer-reviewed clinical neurology journal for the practicing neurologist
  • Subscribe
  • My Alerts
  • Log in
  • Log out
Site Logo
  • Home
  • Articles
  • Issues
  • Practice Current
  • Practice Buzz

Share

June 2017; 7 (3) Research

Barriers and facilitators to ED physician use of the test and treatment for BPPV

Kevin A. Kerber, Jane Forman, Laura Damschroder, Steven A. Telian, Angela Fagerlin, Patricia Johnson, Devin L. Brown, Lawrence C. An, Lewis B. Morgenstern, William J. Meurer
First published May 10, 2017, DOI: https://doi.org/10.1212/CPJ.0000000000000366
Kevin A. Kerber
University of Michigan Health System (KAK, PJ, DLB, LCA, LBM, WJM), Ann Arbor; Veterans Affairs Ann Arbor Healthcare System (JF, LD), MI; Implementation Pathways, LLC (LD, SAT), Lebanon, NH; VA Salt Lake City Center for Informatics Decision Enhancement and Surveillance (IDEAS) (AF); and University of Utah (AF), Salt Lake City.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jane Forman
University of Michigan Health System (KAK, PJ, DLB, LCA, LBM, WJM), Ann Arbor; Veterans Affairs Ann Arbor Healthcare System (JF, LD), MI; Implementation Pathways, LLC (LD, SAT), Lebanon, NH; VA Salt Lake City Center for Informatics Decision Enhancement and Surveillance (IDEAS) (AF); and University of Utah (AF), Salt Lake City.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Damschroder
University of Michigan Health System (KAK, PJ, DLB, LCA, LBM, WJM), Ann Arbor; Veterans Affairs Ann Arbor Healthcare System (JF, LD), MI; Implementation Pathways, LLC (LD, SAT), Lebanon, NH; VA Salt Lake City Center for Informatics Decision Enhancement and Surveillance (IDEAS) (AF); and University of Utah (AF), Salt Lake City.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven A. Telian
University of Michigan Health System (KAK, PJ, DLB, LCA, LBM, WJM), Ann Arbor; Veterans Affairs Ann Arbor Healthcare System (JF, LD), MI; Implementation Pathways, LLC (LD, SAT), Lebanon, NH; VA Salt Lake City Center for Informatics Decision Enhancement and Surveillance (IDEAS) (AF); and University of Utah (AF), Salt Lake City.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angela Fagerlin
University of Michigan Health System (KAK, PJ, DLB, LCA, LBM, WJM), Ann Arbor; Veterans Affairs Ann Arbor Healthcare System (JF, LD), MI; Implementation Pathways, LLC (LD, SAT), Lebanon, NH; VA Salt Lake City Center for Informatics Decision Enhancement and Surveillance (IDEAS) (AF); and University of Utah (AF), Salt Lake City.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia Johnson
University of Michigan Health System (KAK, PJ, DLB, LCA, LBM, WJM), Ann Arbor; Veterans Affairs Ann Arbor Healthcare System (JF, LD), MI; Implementation Pathways, LLC (LD, SAT), Lebanon, NH; VA Salt Lake City Center for Informatics Decision Enhancement and Surveillance (IDEAS) (AF); and University of Utah (AF), Salt Lake City.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Devin L. Brown
University of Michigan Health System (KAK, PJ, DLB, LCA, LBM, WJM), Ann Arbor; Veterans Affairs Ann Arbor Healthcare System (JF, LD), MI; Implementation Pathways, LLC (LD, SAT), Lebanon, NH; VA Salt Lake City Center for Informatics Decision Enhancement and Surveillance (IDEAS) (AF); and University of Utah (AF), Salt Lake City.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lawrence C. An
University of Michigan Health System (KAK, PJ, DLB, LCA, LBM, WJM), Ann Arbor; Veterans Affairs Ann Arbor Healthcare System (JF, LD), MI; Implementation Pathways, LLC (LD, SAT), Lebanon, NH; VA Salt Lake City Center for Informatics Decision Enhancement and Surveillance (IDEAS) (AF); and University of Utah (AF), Salt Lake City.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lewis B. Morgenstern
University of Michigan Health System (KAK, PJ, DLB, LCA, LBM, WJM), Ann Arbor; Veterans Affairs Ann Arbor Healthcare System (JF, LD), MI; Implementation Pathways, LLC (LD, SAT), Lebanon, NH; VA Salt Lake City Center for Informatics Decision Enhancement and Surveillance (IDEAS) (AF); and University of Utah (AF), Salt Lake City.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William J. Meurer
University of Michigan Health System (KAK, PJ, DLB, LCA, LBM, WJM), Ann Arbor; Veterans Affairs Ann Arbor Healthcare System (JF, LD), MI; Implementation Pathways, LLC (LD, SAT), Lebanon, NH; VA Salt Lake City Center for Informatics Decision Enhancement and Surveillance (IDEAS) (AF); and University of Utah (AF), Salt Lake City.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Barriers and facilitators to ED physician use of the test and treatment for BPPV
Kevin A. Kerber, Jane Forman, Laura Damschroder, Steven A. Telian, Angela Fagerlin, Patricia Johnson, Devin L. Brown, Lawrence C. An, Lewis B. Morgenstern, William J. Meurer
Neurol Clin Pract Jun 2017, 7 (3) 214-224; DOI: 10.1212/CPJ.0000000000000366

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
145

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Abstract

Background: The test and treatment for benign paroxysmal positional vertigo (BPPV) are evidence-based practices supported by clinical guideline statements. Yet these practices are underutilized in the emergency department (ED) and interventions to promote their use are needed. To inform the development of an intervention, we interviewed ED physicians to explore barriers and facilitators to the current use of the Dix-Hallpike test (DHT) and the canalith repositioning maneuver (CRM).

Methods: We conducted semi-structured in-person interviews with ED physicians who were recruited at annual ED society meetings in the United States. We analyzed data thematically using qualitative content analysis methods.

Results: Based on 50 interviews with ED physicians, barriers that contributed to infrequent use of DHT/CRM that emerged were (1) prior negative experiences or forgetting how to perform them and (2) reliance on the history of present illness to identify BPPV, or using the DHT but misattributing patterns of nystagmus. Based on participants' responses, the principal facilitator of DHT/CRM use was prior positive experiences using these, even if infrequent. When asked which clinical supports would facilitate more frequent use of DHT/CRM, participants agreed supports needed to be brief, readily accessible, and easy to use, and to include well-annotated video examples.

Conclusions: Interventions to promote the use of the DHT/CRM in the ED need to overcome prior negative experiences with the DHT/CRM, overreliance on the history of present illness, and the underuse and misattribution of patterns of nystagmus. Future resources need to be sensitive to provider preferences for succinct information and video examples.

Evidence-based practice to diagnose and treat benign paroxysmal positional vertigo (BPPV) is established by clinical guideline statements based on randomized controlled trials.1,–,4 The gold standard test for BPPV is the Dix-Hallpike test (DHT), with the positive result indicated by its hallmark pattern of nystagmus: triggered and transient, upbeating-torsional. The treatment is a canalith repositioning maneuver (CRM) (e.g., the Epley maneuver) (videos available at Neurology.org/cp).

Despite the evidence base, prior research indicates the DHT and CRM are substantially underused in emergency department (ED) dizziness visits.5 Patients with BPPV who are not treated with the CRM are often unnecessarily disabled for weeks or longer because of their symptoms.6 In addition, patients with BPPV often needlessly undergo other tests.3,5,–,7

The reasons for the underuse of DHT and CRM have not been well-studied. Misconceptions regarding nystagmus patterns likely exist because ED providers often document nystagmus patterns that conflict with their rendered diagnosis.8 Previous interview data on the general topic of dizziness also suggest that providers overemphasize portions of the history of present illness.9 Thus, interventions to increase appropriate use of the DHT and CRM are needed. The aim of this study was to identify current barriers and facilitators to the use of the DHT and CRM in the ED to inform the design of such an intervention.

METHODS

Sampling and recruitment

We recruited and interviewed emergency medicine physicians from exhibit hall booths at 2 meetings: American College of Emergency Physicians, October 2013, and American Academy of Emergency Medicine, February 2014. Recruitment methods included posters, preconference emails, flyers within registration materials, and a $50 incentive.10

Interview guide development and data collection

To develop topics and questions for the interview guide, we devised a conceptual model, based on the Theory of Planned Behavior (TPB),11 of factors contributing to the use of BPPV processes. TPB posits that the most substantial predictor of behavior is the intention to perform it.12,13 The key determinants of behavioral intent are attitudes, subjective norms, and perceived control.12 We identified several factors influencing these, including outcome expectations, perceived threats, knowledge, culture, training, clinical inertia, personality, incentives, convenience, and prior experiences with dizziness patients and the use of the DHT and CRM. These topics, along with preferences for interventions, were incorporated into the interview guide. Probes were used to encourage greater detail and clarifications.14

Semi-structured interviews were performed in-person. Data were collected regarding career stage, region of practice, and training of residents. The interviews started with general questions about clinical experiences with dizziness patients. Next were questions specific to BPPV and the DHT/CRM. Interviews were performed by one of the investigators (KAK, WJM) or project staff (PJ), after training by our qualitative research expert (JF). Based on preliminary analysis after the first meeting, the interview guide for the second meeting was updated including the use of video examples of nystagmus and knowledge questions regarding the following hallmark patterns of nystagmus: positionally triggered, transient, upbeating-torsional nystagmus (hallmark pattern of posterior canal BPPV); unidirectional spontaneous horizontal nystagmus (hallmark pattern of vestibular neuritis); and bidirectional gaze-evoked nystagmus (hallmark pattern of a CNS lesion).

Data analysis

Interviews were transcribed verbatim and analyzed using NVivo version 10 (QSR International, Melbourne, Australia). Two authors (KAK, WJM) identified themes using qualitative content analysis.15 An initial list of codes was generated based on the interview guide. Using constant comparison, a codebook was developed iteratively. Initial coding was performed by 3 authors (KAK, WJM, PJ). After intercoder agreement was established, the remaining interviews were coded by one author (PJ). Two authors (KAK, WJM) developed findings through memoing of emerging themes throughout the research process, review of code reports, and team discussion. All authors (comprising a multidisciplinary team of physicians, an experimental psychologist, and a qualitative researcher) reviewed the findings. The consolidated criteria for reporting qualitative research (COREQ) guided our study design, data collection, and analysis (appendix e-1).16

Standard protocol approvals, registrations, and patient consents

Institutional review board exemption was received for the study from the University of Michigan.

RESULTS

The study sample was 50 emergency medicine physicians, 26% of whom were women. Stage of career was early for 46%, mid for 36%, and late for 18%. Region of practice was 32% Northeast, 28% South, 24% Midwest, and 16% Western United States. Fifty-six percent reported currently teaching residents. Median interview duration was 18 minutes (interquartile range 16–22). Four major themes emerged regarding barriers or facilitators to the use of the DHT or CRM. Themes, representative quotes, and research comments from in-depth semi-structured interviews are available in tables 1–4.

Theme 1: ED physicians infrequently use the DHT or CRM because of prior negative experiences or difficulty remembering how to perform them

For more details on theme 1, see table 1.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1

Theme 1: Emergency department physicians infrequently use the Dix-Hallpike test (DHT) or the canalith repositioning maneuver (CRM) because of prior negative experiences using these or forgetting how to perform them

Participants typically mentioned BPPV in their differential diagnosis of dizziness presentations, were aware of the DHT and CRM, and 90% had used these previously. However, the DHT and CRM were either infrequently used, even in cases of suspected BPPV, or not used at all by most participants, typically because of negative past experiences. Some participants said they stopped using them because it took too much time.

The typical negative experience was the DHT and CRM not being useful for determining the diagnosis or influencing the management or outcome of patients. Referring to DHT, one physician said, “So, I think I've probably tried several times and it didn't help, so I stopped doing it” (A15). Regarding use of the CRM, another participant said, “I think I haven't done it in a while because I had such a negative experience with it. I've seen the Epley maneuver and I've performed Epley maneuvers on non-sick patients…just practicing. There are YouTube, or I think the Annals, maybe the New England Journal, have a video on how to do the Epley maneuver. I think I'm doing it right. It's not successful in my case series. When I have a neurology attending do the exact same thing…thinking they are more expert at it, I still don't see patient improvement” (A13).

Some participants described experiences of the DHT or CRM worsening patient's symptoms. One participant stopped using the DHT after a memorable experience: “I did it on someone who complained about it to be perfectly honest. And they vomited after the maneuver. And I got a complaint, ‘Why don't [you] stop doing it.’ It affected my behavior. I was asked to stop doing it.” (A02) For some, the negative perception against the DHT/CRM was very strong. One participant recalled a colleague saying “The road to hell is paved with people doing the Dix-Hallpike maneuver” (A22).

Other participants did not use the DHT or CRM because of difficulty remembering the proper techniques. One participant described numerous efforts to learn and remember them: “In the last 20 years, I must have learned it a dozen times…it's one of those things like…I may learn it and if I don't use it, then a month will go by and I need it, and then “what the heck did I do?” And one of the neurologists that we have on staff…he does the Epley maneuver all the time, and he's constantly trying to show it. And I just can't seem to get it through my thick skull, how to do it and when to use it, and I'd like to” (B07).

Theme 2: ED physicians inappropriately rely on the history of present illness (HPI) or use the DHT but misattribute patterns of nystagmus

For more details on theme 2, see table 2.

View this table:
  • View inline
  • View popup
Table 2

Theme 2: Emergency department physicians inappropriately rely on the history of present illness (HPI) or use the Dix-Hallpike test (DHT) but misattribute patterns of nystagmus

Participants overwhelmingly relied on the HPI and particularly the type of dizziness (e.g., vertigo, lightheadedness) when considering causes of dizziness. One participant said, “The first thing I do is really try to nail down, is this vertigo, is this lightheadedness, or what do you mean when you say dizziness? Because I think that's my first branch” (A14). Participants generally focused on discriminating episodic symptoms vs constant symptoms, and positional triggers of symptoms when considering the possibility of BPPV.

Participants' overreliance on the HPI was particularly apparent when asked how they distinguish BPPV from vestibular neuritis. One participant said, “[For vestibular neuritis] I'm expecting some preceding viral prodrome or those sorts of things. If you don't have any other symptoms aside from the dizziness and if it's, you know, head movement causes my symptoms, then it definitely lends me to thinking it's BPPV” (A21). Some participants used simple heuristics: “I tend to call it BPPV if I think it is an isolated vertigo without accompanying symptoms” (A10). Even when prompted to describe examination elements that distinguish these entities, participants were generally either not able to describe any (e.g., “Not that I remember”) or reinforced their reliance on HPI: “So, there really isn't any physical finding beyond that with respect to the history” (B05). Other participants expressed apathy regarding identifying key components of BPPV or discriminating BPPV from vestibular neuritis and instead focused exclusively on identifying signs of a central lesion.

The HPI items were generally less relied on specifically for identifying central causes of dizziness and making decisions about the use of neuroimaging. Some participants did emphasize information about the onset characteristics (e.g., suddenness of onset, lack of positional components), other central symptoms, and the type of dizziness, with vertigo less likely to be central and disequilibrium or lightheadedness more likely to be central. However, the information most relied on to identify central disorders was older age (“If you're 80 and dizzy, you're getting a CT. If you're 30 and dizzy, you're almost never getting one” [B19]), general neurologic examination abnormalities (particularly coordination and gait abnormalities: “Can't walk, you can't go home” [A03]), presence of cardiovascular risk factors, lack of prior similar symptoms, and the lack of symptom improvement during the ED visit. Neuroimaging was considered a key part of identifying central disorders, though limitations to both CT and MRI were often expressed: “CAT scans aren't sensitive, MRIs take forever” (B15). A nystagmus assessment was infrequently mentioned as a key part of identifying central causes of dizziness. When used, participants said vertical or rotary nystagmus indicated a central disorder whereas horizontal or fatiguing nystagmus indicated a peripheral disorder. A few participants mentioned the head impulse test; however, these people reported difficulty with the test (“Its kind of hard to do that damn test” [B22]) or misconceptions interpreting it.

When participants did use the DHT to diagnose BPPV, their interpretation of the test was often based on whether it elicited dizziness symptoms without regard to nystagmus. Further, when nystagmus was included in the interpretation of the test, participants often considered only its presence or absence, without regard to its vector or other features (e.g., duration), or incorrectly specified the typical BPPV nystagmus characteristics. Some participants expressed difficulty in recognizing features of nystagmus. One participant said, “It's really hard to do. Which direction the fast component is, sometimes helps, although again it's very difficult in the ER to do. It's almost a yes there, not noted, nothing there at all. I don't have very good luck doing, you know, fast to slow nystagmus, one way or another” (A16). After being shown videotapes of hallmark patterns of nystagmus, participants nearly always incorrectly attributed patterns to disorders. Participants typically misattributed the hallmark nystagmus of vestibular neuritis to being BPPV and misattributed the hallmark nystagmus of BPPV to being a central lesion.

The one participant who demonstrated an expert level of ability in distinguishing BPPV and vestibular neuritis described experiences with colleagues this way: “Even my colleagues don't understand vertigo. They don't understand the simplest distinctions between benign positional vertigo and the other peripheral vertigos vs central. Our textbooks in emergency medicine tend to be wrong about certain particulars and the fault lies mostly in trying to lump benign positional vertigo discussions with the other peripheral vertigos.” This participant also expressed frustration in teaching others at the bedside, stating: “I just can't break through” (B22).

Theme 3: Positive prior experiences with the DHT/CRM facilitated DHT/CRM use

For more details on theme 3, see table 3.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 3

Theme 3: Positive prior experiences with the Dix-Hallpike test (DHT)/canalith repositioning maneuver (CRM) facilitated DHT/CRM use

Only a few participants reported occasional or routine use of the DHT/CRM in dizziness patients, all of whom described positive prior experiences. The positive experiences included using the DHT to successfully diagnose BPPV or seeing patients improve, often dramatically, after use of CRM. One participant said, “Certainly my most successful patient was my mother…I did the Epley maneuver and she got dramatically better” (A03). One participant exhibited an expert level of knowledge related to diagnosing and treating BPPV and reported using the DHT/CRM “all the time.” This participant emphasized how frequently the DHT helped distinguish among the various possible causes of dizziness, and specifically to identify BPPV based on the hallmark elicited pattern of nystagmus. He stated not needing to order other tests when the DHT was positive as another positive experience. However, among the other participants who described positive experiences, nearly all misattributed hallmark patterns of nystagmus. One participant who believed the DHT was helpful, but not the CRM, incorrectly reported that “horizontal nystagmus” indicated a positive DHT for BPPV (A02).

We explored several other factors that might influence DHT or CRM use. Social norms did not facilitate use because the few frequent users of the DHT or CRM reported that most of their colleagues were not users. There was very little awareness of published BPPV clinical guidelines or the CRM CPT billing code among users and nonusers. Prior training in residency or from continuing medical education did not seem to contribute to positive experiences or facilitate DHT/CRM use since many participants who described negative experiences also reported prior training. The participant exhibiting expert knowledge in BPPV learned about the DHT/CRM from a textbook on vestibular disorders, which he read because of being “fascinated by neurology” (B22).

Theme 4: Resources to facilitate use of the DHT/CRM should be brief, readily accessible, and easy to use, and include video examples

For more details on theme 4, see table 4.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 4

Theme 4: Resources to facilitate use of the Dix-Hallpike test/canalith repositioning maneuver should be brief, readily accessible, and easy to use, and include video examples

Participants preferred clinical tools and resources that are brief, readily accessible, and easy to use. One participant said, “Just drill it down to something that's short and sweet and not a lot of fluff, and gets me the information I need in a short amount of time” (B07). Some participants said they would use educational resources outside of work hours to learn more about BPPV, but most said they would likely use them at the point of care. Some participants expressed an interest in more in-depth background material but most agreed that educational approaches should take less than 10 minutes to complete.

Participants preferred video-based resources and often sought these out. Many participants specifically mentioned searching YouTube for instructional videos, including for the DHT/CRM. Participants liked using videos for personal learning, and for teaching residents, colleagues, and even patients. Regarding nystagmus, participants preferred having multiple video examples so they could compare and contrast different patterns of nystagmus. Participants also said that videos should be well-narrated or annotated so that key features are clear. One participant, who misattributed the examples of nystagmus patterns, highlighted the value of video examples: “That was pretty dramatic ‘cause that's something I didn't know, and I didn't know I didn't know it. So it was all the better [way] to teach me” (B10). The one participant who demonstrated expert knowledge in BPPV and frustration teaching others said: “I think that [video examples of nystagmus patterns] can help especially with some good video images that describe what you're trying to get across” (B22).

In terms of platform, participants generally favored smartphone apps over websites because apps would be more readily accessible for regular use, especially because some websites may be restricted at work. Other factors often mentioned were the importance of endorsement by a trusted source including links to key studies that contributed to the evidence base.

When asked about the value of in-person training sessions, participants said CME sessions were memorable when the speaker was dynamic and used humor. In addition, participants expressed a preference for hands-on training experiences.

DISCUSSION

We identified negative past experiences with the DHT or CRM as the most common barrier to providers currently using them. Negative experiences included a perceived lack of benefit of the DHT to the diagnostic assessment, lack of patient benefit from the CRM, and worsening of the patient's symptoms. We also found that ED physicians inappropriately rely on HPI information to identify BPPV and generally do not consider nystagmus in the decision-making process or they misattribute patterns of nystagmus. These additional factors are barriers to the current use of the DHT and CRM likely by directly relating to negative experiences. Overreliance on the HPI and not properly incorporating a nystagmus assessment would lead providers to incorrectly select patients for the DHT and CRM, which in turn would set them up for negative experiences.

Our finding of the infrequent use of the DHT and CRM by frontline providers is consistent with prior medical record review and patient survey research.5,6,17 Our findings also affirm prior research that found ED providers frequently misattribute patterns of nystagmus based on documented nystagmus descriptions that conflict with the peripheral vestibular disorders they diagnose.8,18 Our participants were generally not able to provide details about the characteristics of nystagmus that distinguish BPPV from vestibular neuritis, or they incorrectly attributed nystagmus characteristics to the specific disorders. This could easily lead physicians to attempt the DHT or CRM in patients with non-BPPV disorders such as vestibular neuritis. The use of the DHT or CRM in patients with vestibular neuritis, for example, would be expected to result in symptom exacerbation without any potential for benefit. Participants also typically misattributed the hallmark BPPV pattern of nystagmus to a central disorder. This finding means that opportunities could also be missed to use the CRM in the circumstance when it is most likely to help.

Overreliance on the HPI in the identification of BPPV is another factor that could directly lead to negative experiences. Patients are often vague and unreliable in reporting their dizziness type,19 and types of dizziness are not valid discriminators of common causes of dizziness.19 Overreliance on other HPI elements, such as timing and triggers, is also a problem since BPPV and non-BPPV patients can report similar characteristics.20 If ED providers are too inclusive in using the HPI to identify BPPV, then negative experiences with the DHT and CRM could result. Conversely, if providers are too restrictive in using the HPI, then they could miss opportunities for positive experiences.

Educational or reminder interventions aiming to promote DHT/CRM use will need to be brief, readily accessible, and easy to use at the point of care. To facilitate proper DHT/CRM use, video examples of hallmark patterns nystagmus will likely be necessary. Because providers often report difficulty identifying the direction of nystagmus, it may be more effective for them to focus on recognizing the triggered (i.e., no nystagmus at rest but triggered by the DHT) and transient nature of BPPV nystagmus. To reduce the chance of performing the DHT on the wrong patients, an intervention will need to convey the important step of first assessing the patient for spontaneous and gaze-evoked nystagmus before deciding whether to perform the DHT.

The limitations of this study include that our findings may not represent the full range of ED provider experiences. Responses to interview questions could have been biased by perceptions of social desirability. Additional important barriers or facilitators may have been missed.

Interventions aimed at increasing appropriate use of the DHT and CRM need to promote appropriate nystagmus assessments in selecting patients for the DHT and CRM and also to reduce provider overreliance on the HPI. Interventions should include annotated or narrated nystagmus videos, be brief and easy to access at the point of care, and incorporate hands-on training opportunities if possible.

AUTHOR CONTRIBUTIONS

K.A.K., J.F., L.D., S.A.T., A.F., P.J., D.L.B., L.C.A., L.B.M., and W.J.M. made substantial contributions to the concept or design of the study. K.A.K., W.J.M., and P.J. acquired the data. K.A.K., J.F., L.D., P.J., and W.J.M. planned or performed the statistical analysis. K.A.K. drafted the manuscript. All authors contributed to planning, interpretation, and writing of the manuscript and critically revised the manuscript for intellectual content.

STUDY FUNDING

Research reported in this publication was supported by the National Institute on Deafness and Other Communication Disorders of the NIH under award number R01DC012760. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

DISCLOSURES

K.A. Kerber has received author honoraria from Elsevier Inc.; has received funding for travel and/or speaker honoraria from the American Academy of Neurology, GN Otometrics, Abbott Pharmaceutical, and University of Illinois College of Medicine at Peoria; serves as Innovations in Care Delivery Section coeditor for Neurology®; receives publishing royalties for Clinical Neurophysiology of the Vestibular System, 4th edition (Oxford University Press, 2011); serves as a consultant for American Academy of Neurology, University of California San Francisco, and Best Doctors, Inc.; and receives research support from NIH/NIDCD and AHRQ. J. Forman has received funding for travel and/or speaker honoraria from Dublin City University and receives research support from NIH/NIA, AHRQ, the US Veterans Administration, HRET/CDC, Robert Wood Johnson Foundation, Donaghue Foundation, American Hospital Association, and Health Research and Educational Trust. L. Damschroder has received funding for travel and speaker honoraria from Waypoint Research Institute and University of Kansas; serves as a consultant for Implementation Pathways, LLC; and receives research support from US Veterans Administration, Oregon University Health Sciences, University of Michigan, University of Kansas, University of South Florida, University of Pennsylvania, and Duke University. S.A. Telian serves on the editorial board of Otology-Neurotology. A. Fagerlin served on the editorial board for Health Psychology and receives research support from NIH, AHRQ, EU Commission, National Science Foundation, US Veterans Administration, PCORI, and Robert Wood Johnson Foundation. P. Johnson reports no disclosures. D.L. Brown serves as a Steering Committee Member for the Northern Manhattan Initiative for Minority involvement in Clinical Trials; has received funding for travel or speaker honoraria from the Associated Professional Sleep Societies; serves on the editorial boards of Neurology and Stroke; and receives research support from CVR Global, Inc., AHRQ, NIH (National Institute of Neurological Disorders and Stroke, NHLBI), Blue Cross Blue Shield of Michigan Foundation, and Michigan Department of Community Health. L.C. An reports no disclosures. L.B. Morgenstern has received funding for travel and speaker honoraria from the American Heart Association and receives research support from NIH (NINDS, NIMHD, NIDCD) and AHRQ. W.J. Meurer serves as Decision Editor for Annals of Emergency Medicine and Methodology Statistics Reviewer for Academic Emergency Medicine and receives research support from Massey Foundation for TBI research. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/cp.

Embedded Image

Footnotes

  • Funding information and disclosures are provided at the end of the article. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/cp.

  • Supplemental data at Neurology.org/cp

  • Received January 20, 2017.
  • Accepted March 1, 2017.
  • © 2017 American Academy of Neurology

REFERENCES

  1. 1.↵
    1. Hilton MP,
    2. Pinder DK
    . The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo. Cochrane Database Syst Rev 2014;12:CD003162.
    OpenUrlPubMed
  2. 2.↵
    1. Fife TD,
    2. Iverson DJ,
    3. Lempert T, et al
    . Practice parameter: therapies for benign paroxysmal positional vertigo (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2008;70:2067–2074.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Bhattacharyya N,
    2. Baugh RF,
    3. Orvidas L, et al
    . Clinical practice guideline: benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 2008;139:S47–S81.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Brown MD
    . Evidence-based emergency medicine: is the canalith repositioning maneuver effective in the acute management of benign positional vertigo? Ann Emerg Med 2011;58:286–287.
    OpenUrlPubMed
  5. 5.↵
    1. Kerber KA,
    2. Burke JF,
    3. Skolarus LE, et al
    . Use of BPPV processes in emergency department dizziness presentations: a population-based study. Otolaryngol Head Neck Surg 2013;148:425–430.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. von Brevern M,
    2. Radtke A,
    3. Lezius F, et al
    . Epidemiology of benign paroxysmal positional vertigo: a population based study. J Neurol Neurosurg Psychiatry 2007;78:710–715.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Polensek SH,
    2. Tusa R
    . Unnecessary diagnostic tests often obtained for benign paroxysmal positional vertigo. Med Sci Monit 2009;15:MT89–MT94.
    OpenUrlPubMed
  8. 8.↵
    1. Kerber KA,
    2. Morgenstern LB,
    3. Meurer WJ, et al
    . Nystagmus assessments documented by emergency physicians in acute dizziness presentations: a target for decision support? Acad Emerg Med 2011;18:619–626.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Stanton VA,
    2. Hsieh YH,
    3. Camargo CA Jr., et al
    . Overreliance on symptom quality in diagnosing dizziness: results of a multicenter survey of emergency physicians. Mayo Clin Proc 2007;82:1319–1328.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Asch S,
    2. Connor SE,
    3. Hamilton EG,
    4. Fox SA
    . Problems in recruiting community-based physicians for health services research. J Gen Intern Med 2000;15:591–599.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Ajzen I
    . The theory of planned behavior. Organizational Behav Hum Decis Process 1991;50:179–211.
    OpenUrl
  12. 12.↵
    1. Armitage CJ,
    2. Conner M
    . Efficacy of the theory of planned behaviour: a meta-analytic review. Br J Soc Psychol 2001;40:471–499.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Godin G,
    2. Kok G
    . The theory of planned behavior: a review of its applications to health-related behaviors. Am J Health Promot 1996;11:87–98.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Weiss RS
    . Learning from Strangers: The Art and Method of Qualitative Interview Studies. New York: Maxwell Macmillian International; 1994.
  15. 15.↵
    1. Jacoby L,
    2. Siminoff L
    1. Forman J,
    2. Damschroder LJ
    . Qualitative content analysis. In: Jacoby L, Siminoff L, eds. Empirical Research for Bioethics: A Primer. New York: Elsevier; 2007.
  16. 16.↵
    1. Tong A,
    2. Sainsbury P,
    3. Craig J
    . Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 2007;19:349–357.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Polensek SH,
    2. Sterk CE,
    3. Tusa RJ
    . Screening for vestibular disorders: a study of clinicians' compliance with recommended practices. Med Sci Monit 2008;14:CR238–242.
    OpenUrlPubMed
  18. 18.↵
    1. Newman-Toker DE,
    2. Stanton VA,
    3. Hsieh YH,
    4. Rothman RE
    . Frontline providers harbor misconceptions about the bedside evaluation of dizzy patients. Acta Otolaryngol 2008;128:601–604.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Newman-Toker DE,
    2. Cannon LM,
    3. Stofferahn ME,
    4. Rothman RE,
    5. Hsieh YH,
    6. Zee DS
    . Imprecision in patient reports of dizziness symptom quality: a cross-sectional study conducted in an acute care setting. Mayo Clin Proc 2007;82:1329–1340.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Whitney SL,
    2. Marchetti GF,
    3. Morris LO
    . Usefulness of the dizziness handicap inventory in the screening for benign paroxysmal positional vertigo. Otol Neurotol 2005;26:1027–1033.
    OpenUrlCrossRefPubMed

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • METHODS
    • RESULTS
    • DISCUSSION
    • AUTHOR CONTRIBUTIONS
    • STUDY FUNDING
    • DISCLOSURES
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Disclosures
Advertisement

SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy

Dr. Jeffrey Allen and Dr. Nicholas Purcell

► Watch

Topics Discussed

  • All Health Services Research
  • All Neurotology
  • Vertigo

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Article
    Capturing acute vertigo
    A vestibular event monitor
    Allison S. Young, Corinna Lechner, Andrew P. Bradshaw et al.
    Neurology, May 15, 2019
  • Articles
    Predicting a successful treatment in posterior canal benign paroxysmal positional vertigo
    Hui Jong Oh, Ji Soo Kim, Byung In Han et al.
    Neurology, April 09, 2007
  • Article
    Central paroxysmal positional nystagmus
    Characteristics and possible mechanisms
    Jeong-Yoon Choi, Ji Hyun Kim, Hyo Jung Kim et al.
    Neurology, May 08, 2015
  • Clinical and Ethical Challenges
    The evaluation of a patient with dizziness
    Kevin A. Kerber, Robert W. Baloh et al.
    Neurology: Clinical Practice, December 01, 2011
Neurology: Clinical Practice: 13 (3)

Articles

  • Articles
  • Issues
  • Popular Articles

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology: Clinical Practice |  Print ISSN: 2163-0402
Online ISSN: 2163-0933

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise